Traditional Chinese Medicine Containing Arsenic Treated MDS Patients Effectively through Regulating Aberrant Hypomethylation

Table 2

Hematological improvements induced by CM treatment in 130 MDS-RCMD patients.

Parameter	Case (%)	95% CI
HI-E (n = 103)	80 (77.67)	69.63–85.71
HI-N (n = 91)	48 (52.75)	42.5–63.00
HI-P (n = 115)	62 (53.91)	44.80–63.02
Bilineage (HI-E and HI-N, n = 74)	37 (50.00)	38.60–61.39
Bilineage (HI-N and HI-P, n = 74)	27 (36.49)	25.52–47.45
Bilineage (HI-P and HI-E, n = 84)	46 (54.76)	44.12–65.40
Trilineage (HI-E, HI-N and HI-P, n = 66)	26 (39.39)	27.60–51.18
HI-E or HI-N or HI-P (n = 135)	106 (78.52)	71.59–85.45